InsidersTradesSigma
Follow the LAKEFRONT BIOTHERAPEUTICS stock price and the full insider trade history of the company, a publicly traded company based in Belgium. Shares are quoted on the BE market, under the supervision of FSMA. Market capitalisation: €1.6bn. The latest transaction was filed on 12 May 2026 (Purchase). Among the most active insiders: EcoR1 Capital Fund, L.P.. All data is openly available.
56
Insider Decl.
n/a
Thresholds
€46m
53 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LAKEFRONT BIOTHERAPEUTICS Hold (neutral), based on 8 analysts. Average price target: €30.28.
15Σ signal
Fundamental score
Ranked 1,237 of 28,932 companies
79.8
score / 100
Value67
Quality93
FCF yld-16%
Earn yld19%
EV/EBITDA4.7x
ROE20%
Gross mgn97%
Net mgn29%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 May 2026
Declarations56 total
3,215 shares@ €23.6932.4% of flowShareOtherISIN BE0003818359FSMA:lakefront-biotherapeutics-0
6,785 shares@ €23.4567.6% of flowShareOtherISIN BE0003818359FSMA:lakefront-biotherapeutics
353,700 shares0Options /warrants for employees or managersOff exchangeISIN BE0003818359FSMA:lakefront-biotherapeutics-15
108,800 shares0Options /warrants for employees or managersOff exchangeISIN BE0003818359FSMA:lakefront-biotherapeutics-12
108,800 shares0Options /warrants for employees or managersOff exchangeISIN BE0003818359FSMA:lakefront-biotherapeutics-7
235,000 shares0Options /warrants for employees or managersOff exchangeISIN BE0003818359FSMA:lakefront-biotherapeutics-4
1,559 shares@ €28.84100.0% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-13
378 shares@ €28.8433.3% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-5
235,000 shares0Options /warrants for employees or managersOff exchangeISIN BE0003818359FSMA:lakefront-biotherapeutics-1
378 shares@ €28.8433.3% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-3
375 shares@ €28.76100.0% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-9
378 shares@ €28.8433.3% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-2
137 shares@ €28.84100.0% of flowShareEuronext BrusselsISIN BE0003818359FSMA:lakefront-biotherapeutics-10
6,336 shares@ €33.267.3% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-5
89,520 shares@ €33.267.0% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-28
127,041 shares@ €32.369.7% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-30
8,992 shares@ €32.3610.0% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-40
16,651 shares@ €30.4317.5% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-22
235,260 shares@ €30.4316.8% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-16
5,129 shares@ €28.305.0% of flowADR / ADSOtherISIN BE0003818359FSMA:galapagos-65
25 of 56 declarations
About LAKEFRONT BIOTHERAPEUTICS
Lakefront Biotherapeutics is a company focused on developing innovative biological therapies. It operates in the XBRU market.